These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7684215)

  • 1. Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    McMahon JB; Gulakowski RJ; Weislow OS; Schultz RJ; Narayanan VL; Clanton DJ; Pedemonte R; Wassmundt FW; Buckheit RW; Decker WD
    Antimicrob Agents Chemother; 1993 Apr; 37(4):754-60. PubMed ID: 7684215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction.
    Bader JP; McMahon JB; Schultz RJ; Narayanan VL; Pierce JB; Harrison WA; Weislow OS; Midelfort CF; Stinson SF; Boyd MR
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6740-4. PubMed ID: 1713689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors.
    Buckheit RW; Fliakas-Boltz V; Decker WD; Roberson JL; Pyle CA; White EL; Bowdon BJ; McMahon JB; Boyd MR; Bader JP
    Antiviral Res; 1994 Sep; 25(1):43-56. PubMed ID: 7529014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
    Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
    Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nucleoside inhibitors.
    Rubinek T; McMahon JB; Hizi A
    FEBS Lett; 1994 Aug; 350(2-3):299-303. PubMed ID: 7520874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of pyrryl aryl sulfones targeted at the HIV-1 reverse transcriptase.
    Artico M; Silvestri R; Stefancich G; Massa S; Pagnozzi E; Musu D; Scintu F; Pinna E; Tinti E; La Colla P
    Arch Pharm (Weinheim); 1995 Mar; 328(3):223-9. PubMed ID: 7539250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
    Fujihashi T; Sakata T; Kaji A; Kaji H
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
    Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Casimiro-Garcia A; Hejchman E; Ruell JA; Huang M; Schaeffer CA; Williamson K; Rice WG; Buckheit RW
    J Med Chem; 1998 Jun; 41(12):2076-89. PubMed ID: 9622549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.
    Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF
    Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor.
    Buckheit RW; Hollingshead MG; Germany-Decker J; White EL; McMahon JB; Allen LB; Ross LJ; Decker WD; Westbrook L; Shannon WM
    Antiviral Res; 1993 Jul; 21(3):247-65. PubMed ID: 7692815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase.
    Fujihashi T; Hara H; Sakata T; Mori K; Higuchi H; Tanaka A; Kaji H; Kaji A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2000-7. PubMed ID: 8540706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells.
    Rideout D; Schinazi R; Pauza CD; Lovelace K; Chiang LC; Calogeropoulou T; McCarthy M; Elder JH
    J Cell Biochem; 1993 Apr; 51(4):446-57. PubMed ID: 7684385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors.
    Xu G; Micklatcher M; Silvestri MA; Hartman TL; Burrier J; Osterling MC; Wargo H; Turpin JA; Buckheit RW; Cushman M
    J Med Chem; 2001 Nov; 44(24):4092-113. PubMed ID: 11708913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.
    Dueweke TJ; Poppe SM; Romero DL; Swaney SM; So AG; Downey KM; Althaus IW; Reusser F; Busso M; Resnick L
    Antimicrob Agents Chemother; 1993 May; 37(5):1127-31. PubMed ID: 7685995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and specific inhibition of human immunodeficiency virus type 1 replication by 4-(2,6-dichlorophenyl)-1,2,5-thiadiazol-3-Y1 N,N-dialkylcarbamate derivatives.
    Ijichi K; Fujiwara M; Hanasaki Y; Watanabe H; Katsuura K; Takayama H; Shirakawa S; Sakai S; Shigeta S; Konno K
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2337-40. PubMed ID: 8619592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication.
    Rawle DJ; Li D; Wu Z; Wang L; Choong M; Lor M; Reid RC; Fairlie DP; Harris J; Tachedjian G; Poulsen SA; Harrich D
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
    Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
    J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.